Activation of the Sirtuin Silent Information Regulator 1 Pathway Inhibits Pathological Myocardial Remodeling

Overview

Journal Front Pharmacol

Date 2023 Feb 27

PMID 36843938

Authors

Youheng Wang

Rusheng Zhao

Chengyan Wu

Xuefei Liang

Lei He

Libo Wang

Xuehui Wang

Affiliations

Soon will be listed here.

Abstract

Myocardial remodeling refers to structural and functional disorders of the heart caused by molecular biological changes in the cardiac myocytes in response to neurological and humoral factors. A variety of heart diseases, such as hypertension, coronary artery disease, arrhythmia, and valvular heart disease, can cause myocardial remodeling and eventually lead to heart failure. Therefore, counteracting myocardial remodeling is essential for the prevention and treatment of heart failure. Sirt1 is a nicotinamide adenine dinucleotide-dependent deacetylase that plays a wide range of roles in transcriptional regulation, energy metabolism regulation, cell survival, DNA repair, inflammation, and circadian regulation. It positively or negatively regulates myocardial remodeling by participating in oxidative stress, apoptosis, autophagy, inflammation, and other processes. Taking into account the close relationship between myocardial remodeling and heart failure and the involvement of SIRT1 in the development of the former, the role of SIRT1 in the prevention of heart failure inhibition of myocardial remodeling has received considerable attention. Recently, multiple studies have been conducted to provide a better understanding of how SIRT1 regulates these phenomena. This review presents the progress of research involving SIRT1 pathway involvement in the pathophysiological mechanisms of myocardial remodeling and heart failure.

Citing Articles

exerts cardioprotective effect post myocardial infarction by attenuating myocardial fibrosis and inflammation through SIRT1 signaling pathways.

Xu H, Pang M, Hu C, Xu T, Chen G, Zhang G J Ginseng Res. 2025; 49(2):197-207.

PMID: 40061482 PMC: 11889384. DOI: 10.1016/j.jgr.2025.01.001.

Role of sirtuin 1 in depression‑induced coronary heart disease: Molecular pathways and therapeutic potential (Review).

Zheng S, Yang L, Dai Q, Li X, Masuoka T, Lv J Biomed Rep. 2025; 22(3):46.

PMID: 39882335 PMC: 11775641. DOI: 10.3892/br.2025.1924.

Metrnl and Cardiomyopathies: From Molecular Mechanisms to Therapeutic Insights.

Xu M, Liu X, Lu L, Li Z J Cell Mol Med. 2025; 29(2):e70371.

PMID: 39853716 PMC: 11756984. DOI: 10.1111/jcmm.70371.

Taxifolin Protects Against 5-Fluorouracil-Induced Cardiotoxicity in Mice Through Mitigating Oxidative Stress, Inflammation, and Apoptosis: Possible Involvement of Sirt1/Nrf2/HO-1 Signaling.

Abukhalil M, Al-Alami Z, Alfwuaires M, Imran M, Aladaileh S, Althunibat O Cardiovasc Toxicol. 2025; 25(3):455-470.

PMID: 39827225 DOI: 10.1007/s12012-025-09962-w.

Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence-A Narrative Review.

Rubio-Ruiz M, Plata-Corona J, Soria-Castro E, Diaz-Juarez J, Sanchez-Aguilar M Cells. 2024; 13(17.

PMID: 39273057 PMC: 11394383. DOI: 10.3390/cells13171488.

References

Yuan Y, Ma Z, Zhang X, Xu S, Zeng X, Yang Z . CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1. J Mol Cell Cardiol. 2017; 114:38-47. DOI: 10.1016/j.yjmcc.2017.10.008. View

Um J, Park S, Kang H, Yang S, Foretz M, McBurney M . AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes. 2009; 59(3):554-63. PMC: 2828647. DOI: 10.2337/db09-0482. View

Lu H, Jia C, Wu D, Jin H, Lin Z, Pan J . Fibroblast growth factor 21 (FGF21) alleviates senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the SIRT1-mTOR signaling pathway. Cell Death Dis. 2021; 12(10):865. PMC: 8460788. DOI: 10.1038/s41419-021-04157-x. View

Waldman M, Cohen K, Yadin D, Nudelman V, Gorfil D, Laniado-Schwartzman M . Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'. Cardiovasc Diabetol. 2018; 17(1):111. PMC: 6090985. DOI: 10.1186/s12933-018-0754-4. View

Milne J, Lambert P, Schenk S, Carney D, Smith J, Gagne D . Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007; 450(7170):712-6. PMC: 2753457. DOI: 10.1038/nature06261. View

Planavila A, Dominguez E, Navarro M, Vinciguerra M, Iglesias R, Giralt M . Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart. J Mol Cell Cardiol. 2012; 53(4):521-31. DOI: 10.1016/j.yjmcc.2012.07.019. View

Planavila A, Iglesias R, Giralt M, Villarroya F . Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res. 2010; 90(2):276-84. DOI: 10.1093/cvr/cvq376. View

Wang T, Li X, Sun S . EX527, a Sirt-1 inhibitor, induces apoptosis in glioma via activating the p53 signaling pathway. Anticancer Drugs. 2019; 31(1):19-26. DOI: 10.1097/CAD.0000000000000824. View

Minor R, Baur J, Gomes A, Ward T, Csiszar A, Mercken E . SRT1720 improves survival and healthspan of obese mice. Sci Rep. 2012; 1:70. PMC: 3216557. DOI: 10.1038/srep00070. View

10.

Laddha A, Kulkarni Y . Daidzein mitigates myocardial injury in streptozotocin-induced diabetes in rats. Life Sci. 2021; 284:119664. DOI: 10.1016/j.lfs.2021.119664. View

11.

Jiang Q, Lu M, Li J, Zhu Z . Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1. Cardiovasc Ther. 2021; 2021:5554569. PMC: 8245256. DOI: 10.1155/2021/5554569. View

12.

Forte M, Schirone L, Ameri P, Basso C, Catalucci D, Modica J . The role of mitochondrial dynamics in cardiovascular diseases. Br J Pharmacol. 2020; 178(10):2060-2076. DOI: 10.1111/bph.15068. View

13.

Sciarretta S, Maejima Y, Zablocki D, Sadoshima J . The Role of Autophagy in the Heart. Annu Rev Physiol. 2017; 80:1-26. DOI: 10.1146/annurev-physiol-021317-121427. View

14.

Zhang C, Li C, Chen S, Li Z, Ma L, Jia X . Hormetic effect of panaxatriol saponins confers neuroprotection in PC12 cells and zebrafish through PI3K/AKT/mTOR and AMPK/SIRT1/FOXO3 pathways. Sci Rep. 2017; 7:41082. PMC: 5253660. DOI: 10.1038/srep41082. View

15.

Snopek L, Mlcek J, Sochorova L, Baron M, Hlavacova I, Jurikova T . Contribution of Red Wine Consumption to Human Health Protection. Molecules. 2018; 23(7). PMC: 6099584. DOI: 10.3390/molecules23071684. View

16.

Zhang J, Huang L, Shi X, Yang L, Hua F, Ma J . Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway. Aging (Albany NY). 2020; 12(23):24270-24287. PMC: 7762510. DOI: 10.18632/aging.202143. View

17.

Brown D, Perry J, Allen M, Sabbah H, Stauffer B, Shaikh S . Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2016; 14(4):238-250. PMC: 5350035. DOI: 10.1038/nrcardio.2016.203. View

18.

Zhan H, Huang F, Niu Q, Jiao M, Han X, Zhang K . Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1/PIK3R1 Multiple Targets. Oxid Med Cell Longev. 2021; 2021:8889195. PMC: 8505057. DOI: 10.1155/2021/8889195. View

19.

Safari F, Shekarforoosh S, Hashemi T, Namvar Aghdash S, Fekri A, Safari F . Sirtinol abrogates late phase of cardiac ischemia preconditioning in rats. J Physiol Sci. 2016; 67(4):515-522. PMC: 10717902. DOI: 10.1007/s12576-016-0483-y. View

20.

Li S, Huang Q, Zhang L, Qiao X, Zhang Y, Tang F . Effect of CAPE-pNO against type 2 diabetes mellitus via the AMPK/GLUT4/ GSK3β/PPARα pathway in HFD/STZ-induced diabetic mice. Eur J Pharmacol. 2019; 853:1-10. DOI: 10.1016/j.ejphar.2019.03.027. View